Skip to main content
. 2013 Jan 9;56(1):15–21. doi: 10.5468/OGS.2013.56.1.15

Table 3.

Deaths analysis of 100 patients with intermediate risk factors

graphic file with name ogs-56-15-i003.jpg

Values are presented as number (%).

EP, etoposide-cisplatin; FP, 5-fluorouracil-cisplatin.